Paper16190751
Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.
Liu J and 4 others. J Med Chem, 2005. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation. Papers, record 16190751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16190751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| CD2 Antigens | Major topic |
| Peptides | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Binding Sites | |
| CD58 Antigens | |
| Caco-2 Cells | |
| Cell Adhesion | |
| Cell Survival | |
| Epitopes | |
| Humans | |
| In Vitro Techniques | |
| Jurkat Cells | |
| Magnetic Resonance Spectroscopy | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Oligopeptides | |
| Peptides, Cyclic | |
| Protein Structure, Secondary | |
| Sheep | |
| Solutions | |
| Structure-Activity Relationship |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK017420 | NIDDK NIH HHS | United States | R01DK017420 | PubMed and NIH | NIH RePORTER |
| R37 DA012394 | NIDA NIH HHS | United States | R37DA012394 | PubMed and NIH | NIH RePORTER |
| DK 17420 | NIDDK NIH HHS | United States | R01DK017420 | PubMed and NIH | NIH RePORTER |
| DK 334781 | NIDDK NIH HHS | United States | PubMed | PubMed |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11677090 | Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease. | Curr Opin Immunol | 2001 | https://conductscience.org/library/papers/11677090 | PubMed |
| 2 | 11575926 | Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot". | J Mol Biol | 2001 | https://conductscience.org/library/papers/11575926 | PubMed |
| 3 | 12615890 | Molecular interactions mediating T cell antigen recognition. | Annu Rev Immunol | 2003 | https://conductscience.org/library/papers/12615890 | PubMed |
| 4 | 15233784 | Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesion. | Eur J Biochem | 2004 | https://conductscience.org/library/papers/15233784 | PubMed |
| 5 | 15345303 | A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides. | J Immunol Methods | 2004 | https://conductscience.org/library/papers/15345303 | PubMed |
| 6 | 6307308 | Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6307308 | PubMed |
| 7 | 6606682 | Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. | J Immunol Methods | 1983 | https://conductscience.org/library/papers/6606682 | PubMed |
| 8 | 6661238 | Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6661238 | PubMed |
| 9 | 2865874 | Turns in peptides and proteins. | Adv Protein Chem | 1985 | https://conductscience.org/library/papers/2865874 | PubMed |
| 10 | 2838364 | T cell adhesion molecules. | FASEB J | 1988 | https://conductscience.org/library/papers/2838364 | PubMed |
| 11 | 1723296 | Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathway. | Int Immunol | 1991 | https://conductscience.org/library/papers/1723296 | PubMed |
| 12 | 1524219 | Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. | Anal Biochem | 1992 | https://conductscience.org/library/papers/1524219 | PubMed |
| 13 | 1279440 | Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. | Nature | 1992 | https://conductscience.org/library/papers/1279440 | PubMed |
| 14 | 1304345 | Quantitative analysis of cyclic beta-turn models. | Protein Sci | 1992 | https://conductscience.org/library/papers/1304345 | PubMed |
| 15 | 8102072 | Conformational and topographical considerations in the design of biologically active peptides. | Biopolymers | 1993 | https://conductscience.org/library/papers/8102072 | PubMed |
| 16 | 7903681 | Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. | J Exp Med | 1994 | https://conductscience.org/library/papers/7903681 | PubMed |
| 17 | 7915183 | Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. | Structure | 1993 | https://conductscience.org/library/papers/7915183 | PubMed |
| 18 | 7994575 | Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. | Structure | 1994 | https://conductscience.org/library/papers/7994575 | PubMed |
| 19 | 7839434 | Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. | Transplantation | 1995 | https://conductscience.org/library/papers/7839434 | PubMed |
| 20 | 8610340 | Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival. | Transplantation | 1996 | https://conductscience.org/library/papers/8610340 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34017824 | Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions. | Front Chem | 2021 | https://conductscience.org/library/papers/34017824 | PubMed |
| 33532888 | Structure-based identification of inhibitors disrupting the CD2-CD58 interactions. | J Comput Aided Mol Des | 2021 | https://conductscience.org/library/papers/33532888 | PubMed |
| 21755948 | Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58. | J Med Chem | 2011 | https://conductscience.org/library/papers/21755948 | PubMed |
| 19183498 | Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal. | BMC Immunol | 2009 | https://conductscience.org/library/papers/19183498 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD2 | 914 | PubTator's text mining | https://conductscience.org/library/genes/914 | NCBI Gene |
| CD58 | 965 | PubTator's text mining | https://conductscience.org/library/genes/965 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16190751
GET https://conductscience.org/api/papers/v1/16190751/references?page=2